Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry

被引:39
|
作者
Vikingsson, Svante [1 ]
Josefsson, Martin [2 ,3 ]
Green, Henrik [1 ,2 ]
机构
[1] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden
[2] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden
[3] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden
关键词
CANNABINOID RECEPTOR AGONIST; PHASE-I METABOLITES; SYNTHETIC CANNABINOIDS; HUMAN HEPATOCYTES; LC-MS/MS; DESIGNER DRUG; TENTATIVE IDENTIFICATION; QUANTITATIVE MEASUREMENT; JWH-018; METABOLITES; PYROLYSIS PRODUCT;
D O I
10.1093/jat/bkv045
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The occurrence of structurally related synthetic cannabinoids makes the identification of unique markers of drug intake particularly challenging. The aim of this study was to identify unique and abundant metabolites of AKB-48 and 5F-AKB-48 for toxicological screening in urine. Investigations of authentic urine samples from forensic cases in combination with human liver microsome (HLM) experiments were used for identification of metabolites. HLM incubations of AKB-48 and 5F-AKB-48 along with 35 urine samples from authentic cases were analyzed with liquid chromatography quadrupole tandem time of flight mass spectrometry. Using HLMs 41 metabolites of AKB-48 and 37 metabolites of 5F-AKB-48 were identified, principally represented by hydroxylation but also ketone formation and dealkylation. Monohydroxylated metabolites were replaced by di- and trihydroxylated metabolites within 30 min. The metabolites from the HLM incubations accounted for on average 84% (range, 67-100) and 91% (range, 71-100) of the combined area in the case samples for AKB-48 and 5F-AKB-48, respectively. While defluorinated metabolites accounted for on average 74% of the combined area after a 5F-AKB-48 intake only a few identified metabolites were shared between AKB-48 and 5F-AKB-48, illustrating the need for a systematic approach to identify unique metabolites. HLMs in combination with case samples seem suitable for this purpose.
引用
收藏
页码:426 / 435
页数:10
相关论文
共 50 条
  • [1] Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry
    Holm, Niels Bjerre
    Pedersen, Anders Just
    Dalsgaard, Petur Weihe
    Linnet, Kristian
    DRUG TESTING AND ANALYSIS, 2015, 7 (03) : 199 - 206
  • [2] First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry
    Adarsh S. Gandhi
    Mingshe Zhu
    Shaokun Pang
    Ariane Wohlfarth
    Karl B. Scheidweiler
    Hua-fen Liu
    Marilyn A. Huestis
    The AAPS Journal, 2013, 15 : 1091 - 1098
  • [3] First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry
    Gandhi, Adarsh S.
    Zhu, Mingshe
    Pang, Shaokun
    Wohlfarth, Ariane
    Scheidweiler, Karl B.
    Liu, Hua-fen
    Huestis, Marilyn A.
    AAPS JOURNAL, 2013, 15 (04): : 1091 - 1098
  • [4] Oxidative Metabolism and Comparative Analysis of Synthetic Cannabinoid N-(1-adamantyl)-1-(5-fluoropentyl)indazole-3-carboxamide (5F-AKB-48) and the Unfluorinated Analog AKB-48
    Yarbrough, Azure Leigh
    Pinson, Anna
    Prather, Paul L.
    Fantegrossi, William E.
    Bush, John M.
    Fujiwara, Ryoichi
    Radominska-Pandya, Anna
    FASEB JOURNAL, 2019, 33
  • [5] Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine Samples
    Svante Vikingsson
    Ariane Wohlfarth
    Mikael Andersson
    Henrik Gréen
    Markus Roman
    Martin Josefsson
    Fredrik C Kugelberg
    Robert Kronstrand
    The AAPS Journal, 2017, 19 : 736 - 742
  • [6] Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine Samples
    Vikingsson, Svante
    Wohlfarth, Ariane
    Andersson, Mikael
    Green, Henrik
    Roman, Markus
    Josefsson, Martin
    Kugelberg, Fredrik C.
    Kronstrand, Robert
    AAPS JOURNAL, 2017, 19 (03): : 736 - 742
  • [7] Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry
    Ozturk, Yeter Erol
    Yeter, Oya
    Ozturk, Serkan
    Karakus, Goksun
    Ates, Ismail
    Buyuk, Yalcin
    Yurdun, Turkan
    DRUG TESTING AND ANALYSIS, 2018, 10 (03) : 449 - 459
  • [8] Identifying metabolites of diphenidol by liquid chromatography-quadrupole/orbitrap mass spectrometry using rat liver microsomes, human blood, and urine samples
    Yang, Liu
    Zhao, Junbo
    Liu, Mengxi
    Li, Le
    Yang, Huan
    Guo, Caixia
    Hu, Jing
    Xiang, Ping
    Shen, Baohua
    Qiao, Zheng
    Dang, Yonghui
    Shi, Yan
    DRUG TESTING AND ANALYSIS, 2021, 13 (06) : 1127 - 1135
  • [9] Identification and quantification of acetyl tributyl citrate (ATBC) metabolites using human liver microsomes and human urine
    Jeon H.
    Yeo S.
    Park E.-A.
    Kang D.
    Shen K.
    Kim M.
    Lee I.
    Jeon J.
    Moon B.
    Ji K.
    Kim S.
    Kho Y.
    Chemosphere, 2024, 363
  • [10] Isolation from rat urine and human liver microsomes and identification by electrospray and nanospray tandem mass spectrometry of new malagashanine metabolites
    Rafatro, H
    Verbeeck, RK
    Gougnard, TYR
    De Jonghe, PJM
    Rasoanaivo, P
    Laurent, A
    Lhoëst, G
    JOURNAL OF MASS SPECTROMETRY, 2000, 35 (09): : 1112 - 1120